Skip to content

The Glycemic Effect of Added Sugar on Bake Beans

The Glycemic Effect of Added Sugar on Bake Beans

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03868683
Acronym
GIF
Enrollment
12
Registered
2019-03-11
Start date
2018-08-20
Completion date
2019-04-17
Last updated
2020-07-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Type 2, Obesity, PreDiabetes

Brief summary

To investigate the effect of added sugar to bake beans on glycemic and insulinemic response.

Detailed description

There will be a total of 7 test session. Each session will last for 3 hours. At each test session, volunteers will be served with 7 test meals and blood will be collected. After an overnight fast, subjects will visit the research center. Two fasting capillary blood samples will be collected via fingerpick. Following the fasting samples, volunteers will consume the test meals. Further blood samples will be collected at 15, 30, 45, 60, 90, 120, 150, 180 minutes after the ingestion of test meal. These samples will be used to analyses for whole capillary blood glucose. At every 30 minute interval, samples will be collected for analysis of capillary plasma insulin.

Interventions

30 g of glucose dissolved in 250 ml of water

30 g of glucose dissolved in 250 ml of water

30 g of glucose dissolved in 250 ml of water

OTHERSucrose

30 g of Sucrose dissolved in 250 ml of water

OTHERRegular Bake beans in tomato sauce

Bake beans in tomato sauce containing 14 g of sugar

OTHERBake beans in tomato sauce, reduced sugar

Bake beans in tomato sauce containing 12.2 g of sugar

OTHERBake beans in tomato sauce, low GI

Bake beans in tomato sauce containing 7.2 g of sugar

Sponsors

Singapore Institute of Food and Biotechnology Innovation
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
NONE

Intervention model description

Crossover randomized controlled Trials

Eligibility

Sex/Gender
MALE
Age
21 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Chinese ethnicity * Age ≥21 and ≤ 60 years * Body mass index between 18.5 to 25 kg/m2 * Normal blood pressure \<140/90 mmHg * Fasting blood glucose \<6.0 mmol/L * In general good health

Exclusion criteria

* Current Smoker * have any metabolic diseases (such as diabetes, hypertension etc) * have known glucose-6-phosphate dehydrogenase deficiency (G6PD deficiency) * having medical conditions and/or taking medications known to affect glycaemia (glucocorticoids, thyroid hormones, thiazide diuretics) * have intolerances or allergies to any foods * partake in sports at the competitive and/or endurance levels * intentionally restrict food intake

Design outcomes

Primary

MeasureTime frameDescription
Glucose [Up to 180 minutesWhole capillary blood glucose will be measure using Hemocue analyser

Secondary

MeasureTime frameDescription
InsulinUp to 180 minutesCapillary plasma will be measure using Cobas analyser

Countries

Singapore

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026